Psychologic and social sequelae of secondary lymphedema: a review

scientific article

Psychologic and social sequelae of secondary lymphedema: a review is …
instance of (P31):
meta-analysisQ815382
scholarly articleQ13442814

External links are
P356DOI10.1002/CNCR.21195
P698PubMed publication ID15968692
P5875ResearchGate publication ID229725203

P2093author name stringSue P Heiney
Janis McWayne
P2860cites workThe hospital anxiety and depression scaleQ27860968
The McGill Pain Questionnaire: Major properties and scoring methodsQ28205026
The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncologyQ29615701
Reno, a European postmarket surveillance registry, confirms effectiveness of coronary brachytherapy in routine clinical practiceQ33186181
Morbidity related to axillary irradiation in the treatment of breast cancerQ34033298
Effect of upper extremity exercise on secondary lymphedema in breast cancer patients: a pilot studyQ34174136
Quality of life and breast cancer: relationship to psychosocial variablesQ34187523
Psychosocial stages and quality of life of women with breast cancerQ34335297
Body Image for Women: Conceptualization, Assessment, and a Test of its Importance to Sexual Dysfunction and Medical IllnessQ34725501
Breast cancer lymphedema: pathophysiology and risk reduction guidelinesQ34949650
Cancer rehabilitation: particularly with aspects on physical impairmentsQ35189241
Sentinel node in the era of neoadjuvant therapy and locally advanced breast cancerQ35681392
Assessment of morbidity from complete axillary dissectionQ35994379
Lymphedema following the surgical treatment of breast cancer: a review of pathophysiology and treatmentQ36055395
Comparison of quality of life and arm complaints after axillary lymph node dissection vs sentinel lymph node biopsy in breast cancer patientsQ36648233
Lymphedema and quality of life in survivors of early-stage breast cancerQ39635025
The Pain Disability Index: psychometric propertiesQ41198505
The rationale and foundations of group psychotherapy for women with metastatic breast cancerQ41752021
Complications of axillary lymph node dissection for carcinoma of the breast: a report based on a patient surveyQ43444872
Lymphedema after treatment of breast cancer.Q44714509
Lymphedema of the arm and breast in irradiated breast cancer patients: risks in an era of dramatically changing axillary surgeryQ44904471
Prospective trial of complete decongestive therapy for upper extremity lymphedema after breast cancer therapyQ45205034
Sensory morbidity after sentinel lymph node biopsy and axillary dissection: a prospective study of 233 women.Q45231038
Comparative morbidity of axillary lymph node dissection and the sentinel lymph node technique: implications for patients with breast cancer.Q45934179
Effects of two types of social support and education on adaptation to early-stage breast cancerQ47567228
The validation of a quality of life scale to assess the impact of arm morbidity in breast cancer patients post-operativelyQ47573406
Axilla surgery severely affects quality of life: results of a 5-year prospective study in breast cancer patientsQ47870710
[Clinical usefulness and perspectives of sentinel node biopsy in the management of breast cancer]Q50493544
Sentinel node biopsy performed before preoperative chemotherapy for axillary lymph node staging in breast cancer.Q50493807
Long-term adjustment of survivors of early-stage breast carcinoma, 20 years after adjuvant chemotherapy.Q51020218
Breast cancer patients' experiences of lymphoedema.Q51030652
Quality of life of breast cancer patients with lymphedema.Q51090510
Are we using appropriate self-report questionnaires for detecting anxiety and depression in women with early breast cancer?Q51090657
The psychological morbidity of breast cancer-related arm swelling. Psychological morbidity of lymphoedema.Q51138749
Is physical function a more appropriate measure than volume excess in the assessment of breast cancer-related lymphoedema (BCRL)?Q51946482
Base-Line Quality-of-Life Assessment in the National Surgical Adjuvant Breast and Bowel Project Breast Cancer Prevention TrialQ52013512
Psychologic status of community residents along major demographic dimensions.Q52108749
Lymphoedema and reduced shoulder function as indicators of quality of life after axillary lymph node dissection for invasive breast cancer.Q53401050
Physical and psychological morbidity after axillary lymph node dissection for breast cancer.Q53543468
Measurement of health-related quality of life of patients receiving conservative treatment for limb lymphoedema using the Nottingham Health Profile.Q53593790
Reliability and validity of the Functional Assessment of Cancer Therapy-Breast quality-of-life instrument.Q53603230
Lymphedema secondary to postmastectomy radiation: incidence and risk factors.Q53639237
Comparison of side effects between sentinel lymph node and axillary lymph node dissection for breast cancer.Q53664153
The lived experience of breast cancer-related lymphoedema.Q53884131
Eighteen Sensations After Breast Cancer Surgery: A Two-Year Comparison of Sentinel Lymph Node Biopsy and Axillary Lymph Node DissectionQ59721981
Assessing social support: The Social Support Questionnaire.Q61010084
Measuring the Functional Components of Social SupportQ61010169
Long-term postthoracotomy painQ68186847
A structured psychiatric intervention for cancer patients. I. Changes over time in methods of coping and affective disturbanceQ68871481
The psychosocial adjustment to illness scale (PAIS)Q69494595
Standards for qualitative researchQ69969385
Measuring the quality of life of cancer patients: the Functional Living Index-Cancer: development and validationQ70356145
The Karnofsky Performance Status Scale. An examination of its reliability and validity in a research settingQ71293208
Evaluation of the results of three different methods of postmastectomy lymphedema treatmentQ71399765
Lymphedema: the seemingly forgotten complicationQ72197630
Edema volume, not timing, is the key to success in lymphedema treatmentQ73247617
Patients' perceptions of breast-cancer-related lymphoedemaQ73978996
Lymphedema in a cohort of breast carcinoma survivors 20 years after diagnosisQ77357117
Sentinel lymph node biopsy results in less postoperative morbidity compared with axillary lymph node dissection for breast cancerQ77704402
Incidence of breast carcinoma-related lymphedemaQ77751415
Psychosocial aspects of upper extremity lymphedema in women treated for breast carcinomaQ77751436
Current status of education and treatment resources for lymphedemaQ77751464
Breast lymphedema after breast conserving treatmentQ80570031
Treatment-related upper limb morbidity 1 year after sentinel lymph node biopsy or axillary lymph node dissection for stage I or II breast cancerQ80961841
P433issue3
P407language of work or nameEnglishQ1860
P304page(s)457-466
P577publication date2005-08-01
P1433published inCancerQ326041
P1476titlePsychologic and social sequelae of secondary lymphedema: a review
P478volume104

Reverse relations

cites work (P2860)
Q39198203'Abandoned by medicine'? A qualitative study of women's experiences with lymphoedema secondary to cancer, and the implications for care
Q37276873A Comparison of the Quality of Life in Patients With Primary and Secondary Lower Limb Lymphedema: A Mixed-Methods Study
Q38831786A meta-analysis of the effectiveness and safety of kinesiology taping in the management of cancer-related lymphoedema
Q37373883A prospective cohort study defining utilities using time trade-offs and the Euroqol-5D to assess the impact of cancer-related lymphedema
Q39614016A qualitative national focus group study of the experience of living with lymphoedema and accessing local multiprofessional lymphoedema clinics
Q35208321A safety and efficacy pilot study of acupuncture for the treatment of chronic lymphoedema
Q50055183Analysis of Undesirable Sequelae of Sentinel Node Surgery in Breast Cancer Patients - a Prospective Cohort Study.
Q37543409Arm/hand swelling and perceived functioning among breast cancer survivors 12 years post-diagnosis: CALGB 79804.
Q36673822Body image in recently diagnosed young women with early breast cancer
Q37366477Breast and gynecologic cancer-related extremity lymphedema: a review of diagnostic modalities and management options
Q39824536Causes and consequences of lymphatic disease
Q35014862Causes of shoulder pain in women with breast cancer-related lymphedema: a pilot study
Q37042661Cell-Assisted Lipotransfer Using Autologous Adipose-Derived Stromal Cells for Alleviation of Breast Cancer-Related Lymphedema
Q40508710Clinical and Psychosocial Outcomes of Vascularized Lymph Node Transfer for the Treatment of Upper Extremity Lymphedema After Breast Cancer Therapy
Q90352948Comparison of the short-term effects of hyperbaric oxygen therapy and complex decongestive therapy on breast cancer-related lymphedema: A pilot study
Q36416075Complexities of Adherence and Post-Cancer Lymphedema Management
Q48021786Coping and quality of life of patients following microsurgical treatment for breast cancer-related lymphedema
Q37756342Current concepts and future directions in the diagnosis and management of lymphatic vascular disease
Q38165986Do medical procedures in the arm increase the risk of lymphoedema after axillary surgery? A review.
Q92894910Effects of complex decongestive therapy on quality of life, depression, neuropathic pain, and fatigue in women with breast cancer-related lymphedema
Q35398658Effects of phase I complex decongestive physiotherapy on physical functions and depression levels in breast cancer related lymph edema
Q49627304Efficacy of Complementary Therapies in the Quality of Life of Breast Cancer Survivors.
Q48052726Examining pain, body image, and depressive symptoms in patients with lymphedema secondary to breast cancer
Q37946262Exercise in patients with lymphedema: a systematic review of the contemporary literature
Q52602501Extracorporeal shock wave therapy ameliorates secondary lymphedema by promoting lymphangiogenesis
Q51860850Factors related to return to work by women with breast cancer in northern France.
Q37385266G protein-coupled receptors as potential drug targets for lymphangiogenesis and lymphatic vascular diseases
Q36525839Health-related quality of life in breast cancer patients with lymphedema who survived more than one year after surgery
Q37332775Impact of cancer on everyday life: a systematic appraisal of the research evidence.
Q85046379Is lymphedema an unmanageable disease?
Q38239293Lymphaticovenular anastomosis to prevent cellulitis associated with lymphoedema
Q53194244Lymphedema after gynecological cancer treatment : prevalence, correlates, and supportive care needs.
Q34724809Lymphedema after surgery for endometrial cancer: prevalence, risk factors, and quality of life
Q37104754Lymphedema in breast cancer survivors: incidence, degree, time course, treatment, and symptoms
Q34627929Lymphedema prevalence and treatment benefits in cancer: impact of a therapeutic intervention on health outcomes and costs
Q44078724Lymphoedema management: an international intersect between developed and developing countries. Similarities, differences and challenges
Q35824463Perspectives of the Breast Cancer Survivorship Continuum: Diagnosis through 30 Months Post-Treatment
Q34374668Physical activity, long-term symptoms, and physical health-related quality of life among breast cancer survivors: a prospective analysis
Q45164084Physical therapy management of primary lymphedema in the lower extremities: A case report
Q34004921Prescription and adherence to lymphedema self-care modalities among women with breast cancer-related lymphedema
Q38378626Prevention and management of lymphedema after breast cancer treatment
Q36143736Prospective Lymphedema Surveillance in a Clinic Setting
Q24187789Psychological interventions for women with non-metastatic breast cancer
Q24235081Psychological interventions for women with non-metastatic breast cancer
Q34287873Quality of life among a population-based cohort of older patients with breast cancer
Q47806271Quality of life in patients with primary and secondary lymphedema in the community
Q39052241Radiation therapy targets and the risk of breast cancer-related lymphedema: a systematic review and network meta-analysis
Q27009895Recent progress in the treatment and prevention of cancer-related lymphedema
Q37677687Risk Factors Associated with Lymphedema among Postmenopausal Breast Cancer Survivors after Radical Mastectomy and Axillary Dissection in China
Q34293178Risk Factors for Lymphedema after Breast Cancer Treatment
Q34383994Risk factors for lymphedema in a prospective breast cancer survivorship study: the Pathways Study.
Q46539424Risks and benefits of needle use in patients after axillary node surgery
Q41651897Self-measurement of upper extremity volume in women post-breast cancer: reliability and validity study
Q36668256Sequelae following axillary lymph node dissection for breast cancer
Q39422284Serial two-year follow-up after lymphaticovenular anastomosis for the treatment of lymphedema
Q91878059Severe lower limb lymphoedema successfully treated with a two-stage debulking procedure: a case report
Q38255872Stem cells show promising results for lymphoedema treatment--a literature review.
Q57488040Survivorship, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology
Q37050022Symptom Frequency, Intensity, and Distress in Patients with Lower Limb Lymphedema
Q48274102Symptoms and uncertainty in breast cancer survivors in Korea: differences by treatment trajectory
Q38522979Symptoms: Lymphedema
Q40121263Tc-99m-Human Serum Albumin Transit Time as a Measure of Arm Breast Cancer-Related Lymphedema.
Q36968612The Pathways Study: a prospective study of breast cancer survivorship within Kaiser Permanente Northern California
Q41009474The effects of bandaging with an additional pad and taping on secondary arm lymphedema in a patient after mastectomy
Q90222274Ultramicrosurgery: A new approach to treat primary male genital lymphedema
Q86490630[Psychosocial aspects of lymphedema]

Search more.